Agilent Technologies Inc. (NYSE:A) has announced the separation of its Life Science and Chemical Analysis Group into two businesses, Chemical Analysis and Life Sciences. The change in structure reflects the growth opportunities of each business and supports Agilent’s continued evolution as a leading bio-analytical company.
Effective immediately, Mike McMullen has been promoted to senior vice president of Agilent and president of the Chemical Analysis Group. Similarly, Nick Roelofs has been promoted to Agilent SVP and president of the Life Sciences Group. Each had previously been vice president and general manager of his respective unit.
Bill Sullivan, Agilent president and CEO, said, “The decision to create two separate businesses within bio-analytical measurement reflects the need to serve distinct sets of customers, along with Agilent’s commitment to building a stronger presence in bio-analytical markets.”
Agilent will be comprised of three separate business groups -- Electronic Measurement, Chemical Analysis and Life Sciences -- effective Nov. 1, 2009, for reporting purposes.
MGI Unveils Comprehensive Expansion of Automation Product Lines for Life Science and Healthcare Research